SunTrust Reiterates Hold Rating on Humana (HUM) Following Announced Enclara Acquisition

Go back to SunTrust Reiterates Hold Rating on Humana (HUM) Following Announced Enclara Acquisition

Consonance Capital Partners Signs Definitive Agreement to Sell Enclara Healthcare to Humana

December 16, 2019 7:00 AM EST

 

NEW YORK & PHILADELPHIA--(BUSINESS WIRE)-- Consonance Capital Partners, a leading healthcare-focused private equity fund, announced today that it signed a definitive agreement to sell Enclara Healthcare (Enclara), along with management, to Humana Inc. (NYSE: HUM or Humana). Certain assets are excluded from the transaction and terms have not been disclosed. Established over 20 years ago, Enclara is a leading... More

Humana to Acquire Enclara Healthcare

December 16, 2019 6:30 AM EST

LOUISVILLE, Ky. & PHILADELPHIA--(BUSINESS WIRE)-- Humana Inc. (NYSE: HUM) today announced it has signed a definitive agreement to acquire privately held Enclara Healthcare (Enclara), one of the nations largest hospice pharmacy and benefit management providers, from Consonance Capital Partners and Enclara management. Enclara is a leading pharmacy solutions provider focused on simplifying care delivery in complex care populations to improve patient experience, quality and cost.

The Enclara acquisition provides Humana with the opportunity to extend its comprehensive care continuum strategy to cover the pharmacy-related needs associated with hospice care, simplify the... More